Status:
COMPLETED
Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation
Lead Sponsor:
Dr. Alexander Supady
Conditions:
Coronavirus
COVID-19
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
In December 2019 in the city of Wuhan in China, a series of patients with unclear pneumonia was noticed, some of whom have died of it. In virological analyses of samples from the patients' deep respir...
Detailed Description
In December 2019, a series of unexplained cases of pneumonia in the city of Wuhan in China has come to light. In virological analyses of samples from the patients' deep respiratory tract, a novel coro...
Eligibility Criteria
Inclusion
- SARS-CoV-2-infection with COVID-pneumonia
- vv-ECMO therapy
Exclusion
- pregnancy, breastfeeding
Key Trial Info
Start Date :
March 27 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 27 2021
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT04324528
Start Date
March 27 2020
End Date
January 27 2021
Last Update
March 15 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Clinic Freiburg
Freiburg im Breisgau, Germany, 79108